Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Allurion Technologies (ALUR)
NYSE:ALUR
RESEARCH TOOLSreports
Holding ALUR?
Track your performance easily
ALUR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.26 - $4.00
Previous Close$0.35
Volume744.34K
Average Volume (3M)408.17K
Market Cap
$22.55M
Enterprise Value$32.44M
Total Cash (Recent Filing)$28.65M
Total Debt (Recent Filing)$38.55M
Price to Earnings (P/E)―
Beta1.96
Next Earnings
Mar 20, 2025EPS Estimate
-$0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.47
Shares Outstanding64,486,517
10 Day Avg. Volume5,236,870
30 Day Avg. Volume408,169
Standard Deviation0.20
R-Squared0.28
Alpha-0.06
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)-0.35
Price to Sales (P/S)0.85
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.73
Enterprise Value/Gross Profit0.78
Enterprise Value/Ebitda-0.94
Forecast
1Y Price Target
$2.00Price Target Upside474.71% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Allurion Technologies News
PremiumCompany Announcements
Allurion Technologies Reports Q3 2024 Financial Performance
PremiumCompany Announcements
Allurion Technologies CFO Resigns, CEO Steps In
Bulls Say, Bears Say
Bulls Say
Clinical TrialsPositive data from the Audacity trial should enable FDA approval, positioning ALUR's balloon for entry into the US market, which is an $18B opportunity.
Market StrategyAllurionMeds strengthens the company’s U.S. presence by addressing key obesity challenges and unlocking access to the huge growth opportunity in the $100B GLP-1 market.
Product LaunchAllurion is expanding its portfolio with the launch of AllurionMeds, integrating affordable GLP-1 weight loss medications into its AI-driven virtual platform.
Bears Say
Financial PerformanceThird-Quarter Revenue Fell Short of Expectations: Revenue was $5.4M compared to the $8.6M consensus.
Future GuidanceThe company has updated its 2024 guidance and now expects revenue of $30M-$35M compared to $40M-$45M previously.
Sales And Market ChallengesSales in 3Q were hurt by macro headwinds in select markets, de-stocking and the contra-revenue amount tied to the recall in France.
---
Ownership Overview
1.57% Insiders
2.46% Mutual Funds
21.93% Other Institutional Investors
72.17% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ALUR FAQ
What was Allurion Technologies’s price range in the past 12 months?
Allurion Technologies lowest stock price was $0.26 and its highest was $4.00 in the past 12 months.
What is Allurion Technologies’s market cap?
Currently, no data Available
When is Allurion Technologies’s upcoming earnings report date?
Allurion Technologies’s upcoming earnings report date is Mar 20, 2025 which is in 88 days.
How were Allurion Technologies’s earnings last quarter?
Allurion Technologies released its earnings results on Nov 13, 2024. The company reported -$0.14 earnings per share for the quarter, beating the consensus estimate of -$0.182 by $0.042.
Is Allurion Technologies overvalued?
According to Wall Street analysts Allurion Technologies’s price is currently Undervalued.
Does Allurion Technologies pay dividends?
Allurion Technologies does not currently pay dividends.
What is Allurion Technologies’s EPS estimate?
Allurion Technologies’s EPS estimate is -$0.22.
How many shares outstanding does Allurion Technologies have?
Allurion Technologies has 64,797,260 shares outstanding.
What happened to Allurion Technologies’s price movement after its last earnings report?
Allurion Technologies reported an EPS of -$0.14 in its last earnings report, beating expectations of -$0.182. Following the earnings report the stock price went down -26.761%.
Which hedge fund is a major shareholder of Allurion Technologies?
Among the largest hedge funds holding Allurion Technologies’s share is Fortress Investment Group LLC. It holds Allurion Technologies’s shares valued at 773K.
---
Allurion Technologies Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.00 (474.71% Upside)
$2.00 (474.71% Upside)
Blogger Sentiment
Bullish
ALUR Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 12.0K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.9%
Last 30 Days ▼ 2.9%
Last 30 Days ▼ 2.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-89.64%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-57.99%
Trailing 12-Months
Company Description
Allurion Technologies
Compute Health Acquisition Corp is a blank check company.
---
ALUR Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflects a challenging quarter with significant revenue decline and operational difficulties, particularly in France. However, there are promising aspects such as substantial growth in AI product revenue, a new commercial strategy, and positive data from recent studies. The company is focused on restructuring and strategic initiatives to return to growth.Read More>---
ALUR Stock 12 Month Forecast
Average Price Target
$2.00
▲(474.71% Upside)
Technical Analysis
Best Analysts Covering ALUR
1 Year
1 Year Success Rate
0/2 ratings generated profit
1 Year Average Return
-50.05%
assigned a buy rating 28 days ago
Copying Josh Jennings's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -50.05% per trade.
---